Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor.

[1]  Kazuo Maruyama,et al.  Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system. , 2004, Biochemistry.

[2]  R. Jain,et al.  Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft. , 1993, Cancer research.

[3]  J. Viret,et al.  Virosomal adjuvanted antigen delivery systems , 2003, Expert review of vaccines.

[4]  Ricky T. Tong,et al.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer , 2004, Nature Medicine.

[5]  A M Tsatsakis,et al.  Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification. , 2001, Biomaterials.

[6]  S. Shimada,et al.  Improving chemotherapeutic drug penetration in melanoma by imatinib mesylate. , 2008, Journal of dermatological science.

[7]  R. Bartus,et al.  Bradykinin modulation of tumor vasculature: II. activation of nitric oxide and phospholipase A2/prostaglandin signaling pathways synergistically modifies vascular physiology and morphology to enhance delivery of chemotherapeutic agents to tumors. , 2001, The Journal of pharmacology and experimental therapeutics.

[8]  D. P. Sarkar,et al.  Targeted gene delivery by virosomes. , 2002, Methods in molecular biology.

[9]  S. Futaki,et al.  An artificial virus-like nano carrier system: enhanced endosomal escape of nanoparticles via synergistic action of pH-sensitive fusogenic peptide derivatives , 2008, Analytical and bioanalytical chemistry.

[10]  Robert J. Lee,et al.  Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes. , 2008, International journal of pharmaceutics.

[11]  K. Maruyama,et al.  Enhanced tumor targeting of doxorubicin by ganglioside GM1-bearing long-circulating liposomes. , 1993, Journal of drug targeting.

[12]  J. Ruysschaert,et al.  Formation and intracellular trafficking of lipoplexes and polyplexes. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  Jong-Mok Kim,et al.  Cytoplasmic delivery of liposomal contents mediated by an acid-labile cholesterol-vinyl ether-PEG conjugate. , 2009, Bioconjugate chemistry.

[14]  D. Dykxhoorn,et al.  Breaking down the barriers: siRNA delivery and endosome escape , 2010, Journal of Cell Science.

[15]  S W Hui,et al.  Grafted poly-(ethylene glycol) on lipid surfaces inhibits protein adsorption and cell adhesion. , 1997, Biochimica et biophysica acta.

[16]  M. Bally,et al.  Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity , 1999, Nature Biotechnology.

[17]  Kurt Ballmer-Hofer,et al.  Antennapedia and HIV Transactivator of Transcription (TAT) “Protein Transduction Domains” Promote Endocytosis of High Molecular Weight Cargo upon Binding to Cell Surface Glycosaminoglycans* , 2003, Journal of Biological Chemistry.

[18]  Takenori Yamamoto,et al.  MITO-Porter: A liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion. , 2008, Biochimica et biophysica acta.

[19]  Y. Bae,et al.  Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice , 2005, Journal of drug targeting.

[20]  Pamela A. Silver,et al.  Nuclear transport and cancer: from mechanism to intervention , 2004, Nature Reviews Cancer.

[21]  R K Jain,et al.  Transport of molecules in the tumor interstitium: a review. , 1987, Cancer research.

[22]  C. de Lange Davies,et al.  Hyaluronidase-induced periodic modulation of the interstitial fluid pressure increases selective antibody uptake in human osteosarcoma xenografts. , 2000, Anticancer research.

[23]  Hideyoshi Harashima,et al.  Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells. , 2007, International journal of pharmaceutics.

[24]  E. Moase,et al.  Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. , 1995, Biochimica et biophysica acta.

[25]  S. Futaki,et al.  Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system. , 2009, Biological & pharmaceutical bulletin.

[26]  R K Jain,et al.  Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.

[27]  S. Wente.  Gatekeepers of the nucleus. , 2000, Science.

[28]  R K Jain,et al.  Vascular permeability in a human tumour xenograft: molecular charge dependence , 2000, British Journal of Cancer.

[29]  R K Jain,et al.  Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. , 1999, Cancer research.

[30]  W. Hennink,et al.  A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity. , 2003, Bioconjugate chemistry.

[31]  G. Klein,et al.  Kinetics of endosomal pH evolution in Dictyostelium discoideum amoebae. Study by fluorescence spectroscopy. , 1993, Journal of cell science.

[32]  T. Allen,et al.  Long-circulating, polyethylene glycol-grafted immunoliposomes , 1996 .

[33]  Ari Helenius,et al.  Virus entry by macropinocytosis , 2009, Nature Cell Biology.

[34]  Jeremy C Simpson,et al.  Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[35]  D. Hanahan,et al.  Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. , 1998, The Journal of clinical investigation.

[36]  R. K. Jain,et al.  Reduction of interstitial fluid pressure after TNF-alpha treatment of three human melanoma xenografts. , 1996, British Journal of Cancer.

[37]  S. Dietrich,et al.  Understanding Depletion Forces beyond Entropy , 1999 .

[38]  F. Rayne,et al.  HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses. , 2004, Molecular biology of the cell.

[39]  E. Kunieda,et al.  Biodistribution of immunoliposome labeled with Tc-99m in tumor xenografted mice , 2009, Annals of nuclear medicine.

[40]  D. Chandler.  Interfaces and the driving force of hydrophobic assembly , 2005, Nature.

[41]  G. Alvisi,et al.  Tumor-specific nuclear targeting: promises for anti-cancer therapy? , 2006, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[42]  V. Grégoire,et al.  Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[43]  C. Davies,et al.  Collagenase Increases the Transcapillary Pressure Gradient and Improves the Uptake and Distribution of Monoclonal Antibodies in Human Osteosarcoma Xenografts , 2004, Cancer Research.

[44]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[45]  R. Jain,et al.  Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[46]  V. Torchilin,et al.  Cationic liposomes loaded with proapoptotic peptide D-(KLAKLAK)(2) and Bcl-2 antisense oligodeoxynucleotide G3139 for enhanced anticancer therapy. , 2009, Molecular pharmaceutics.

[47]  Moghimi Sm,et al.  Serum factors that regulate phagocytosis of liposomes by Kupffer cells , 1993 .

[48]  M. Wientjes,et al.  Clinical aspects of drug delivery to tumors. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[49]  Robert J. Lee,et al.  Vascular targeting of doxorubicin using cationic liposomes. , 2007, International journal of pharmaceutics.

[50]  W. Jiskoot,et al.  Functional Characterization of an Endosome-disruptive Peptide and Its Application in Cytosolic Delivery of Immunoliposome-entrapped Proteins* , 2002, The Journal of Biological Chemistry.

[51]  H. Harashima,et al.  Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases. , 2008, Advanced drug delivery reviews.

[52]  Steven F Dowdy,et al.  Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis , 2004, Nature Medicine.

[53]  H. Maeda,et al.  Exploiting the enhanced permeability and retention effect for tumor targeting. , 2006, Drug discovery today.

[54]  Shiroh Futaki,et al.  High Density of Octaarginine Stimulates Macropinocytosis Leading to Efficient Intracellular Trafficking for Gene Expression* , 2006, Journal of Biological Chemistry.

[55]  M. van Galen,et al.  Influence of liposome charge on the association of liposomes with Kupffer cells in vitro. Effects of divalent cations and competition with latex particles. , 1985, Biochimica et biophysica acta.

[56]  Natarajan Raghunand,et al.  In vivo imaging of extracellular pH using 1H MRSI , 1999, Magnetic resonance in medicine.

[57]  Huajian Gao,et al.  Size and shape effects on diffusion and absorption of colloidal particles near a partially absorbing sphere: implications for uptake of nanoparticles in animal cells. , 2008, Physical review. E, Statistical, nonlinear, and soft matter physics.

[58]  V. Torchilin,et al.  Transactivating transcriptional activator-mediated drug delivery , 2006, Expert opinion on drug delivery.

[59]  G. Kenner,et al.  Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. , 2007, Biochimica et biophysica acta.

[60]  K. Fujimoto,et al.  A reduction-triggered delivery by a liposomal carrier possessing membrane-permeable ligands and a detachable coating. , 2006, Colloids and surfaces. B, Biointerfaces.

[61]  松平 浩.  Target chemotherapy of anti-CD147 antibody-labeled liposome encapsulated GSH-DXR conjugate on CD147 highly expressed carcinoma cells , 2010 .

[62]  Muthu Kumara Gnanasammandhan,et al.  Optical imaging-guided cancer therapy with fluorescent nanoparticles , 2010, Journal of The Royal Society Interface.

[63]  L. Johansson,et al.  Lowering of tumor interstitial fluid pressure specifically augments efficacy of chemotherapy , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[64]  J. Weinstein,et al.  Interactions of liposomes with mammalian cells. , 1978, Annual review of biophysics and bioengineering.

[65]  C. de Lange Davies,et al.  Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx™) in human osteosarcoma xenografts , 2005, British Journal of Cancer.

[66]  Udo Greiser,et al.  Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells. , 2003, Cancer research.

[67]  A. Curtis,et al.  Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis , 2003, IEEE Transactions on NanoBioscience.

[68]  R. Jain,et al.  Cancer cell death enhances the penetration and efficacy of oncolytic herpes simplex virus in tumors. , 2008, Cancer research.

[69]  Kristian Pietras,et al.  High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.

[70]  Vladimir P Torchilin,et al.  Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[71]  J. Au,et al.  Tumor Priming Enhances Delivery and Efficacy of Nanomedicines , 2007, Journal of Pharmacology and Experimental Therapeutics.

[72]  I. Tannock,et al.  Acid pH in tumors and its potential for therapeutic exploitation. , 1989, Cancer research.

[73]  B. Storrie,et al.  Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum. , 2007, Advanced drug delivery reviews.

[74]  J. Weinstein,et al.  Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. , 1992, Cancer research.

[75]  T. Suhara,et al.  Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo. , 2004, International journal of pharmaceutics.

[76]  E. Giralt,et al.  Cytosolic targeting of macromolecules using a pH-dependent fusogenic peptide in combination with cationic liposomes. , 2009, Bioconjugate chemistry.

[77]  I. Khalil,et al.  Uptake Pathways and Subsequent Intracellular Trafficking in Nonviral Gene Delivery , 2006, Pharmacological Reviews.

[78]  F. Szoka,et al.  Effect of phospholipid composition on an amphipathic peptide-mediated pore formation in bilayer vesicles. , 2000, Biophysical journal.

[79]  Dae-Duk Kim,et al.  Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation. , 2007, International journal of pharmaceutics.

[80]  K. Strebhardt,et al.  Efficient internalization of the polo-box of polo-like kinase 1 fused to an Antennapedia peptide results in inhibition of cancer cell proliferation. , 2002, Cancer research.

[81]  K. Higaki,et al.  Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers. , 2008, International journal of pharmaceutics.

[82]  Ji-Ho Park,et al.  Cooperative nanomaterial system to sensitize, target, and treat tumors , 2009, Proceedings of the National Academy of Sciences.

[83]  K. Rubin,et al.  Inhibition of TGF-β modulates macrophages and vessel maturation in parallel to a lowering of interstitial fluid pressure in experimental carcinoma , 2005, Laboratory Investigation.

[84]  Edrun A. Schnell,et al.  Effect of collagenase and hyaluronidase on free and anomalous diffusion in multicellular spheroids and xenografts. , 2010, Anticancer research.

[85]  R. Reed,et al.  Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. , 1993, Physiological reviews.

[86]  D. Leeper,et al.  Extracellular pH distribution in human tumours. , 1995, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[87]  R. Bellamkonda,et al.  Targeted drug delivery to C6 glioma by transferrin-coupled liposomes. , 2000, Journal of biomedical materials research.

[88]  H. Degani,et al.  Non-invasive imaging of barriers to drug delivery in tumors. , 2008, Microvascular research.

[89]  R. Jain,et al.  Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. , 1991, Cancer research.

[90]  A. Harel,et al.  Importin beta: conducting a much larger cellular symphony. , 2004, Molecular cell.

[91]  Hsin-Ell Wang,et al.  Cancer nanotargeted radiopharmaceuticals for tumor imaging and therapy. , 2009, Anticancer research.

[92]  S. Futaki,et al.  Delivery of condensed DNA by liposomal non-viral gene delivery system into nucleus of dendritic cells. , 2006, Biological & pharmaceutical bulletin.

[93]  S. Awasthi,et al.  Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates. , 2002, Antisense & nucleic acid drug development.

[94]  C. Alving,et al.  Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells. mangala.rao@na.amedd.army.mil. , 2000, Advanced drug delivery reviews.

[95]  R K Jain,et al.  Determinants of tumor blood flow: a review. , 1988, Cancer research.

[96]  D Needham,et al.  Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue. , 1993, Cancer research.

[97]  Jacob N. Israelachvili,et al.  Entropic forces between amphiphilic surfaces in liquids , 1992 .

[98]  Shiroh Futaki,et al.  A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[99]  S. Futaki,et al.  Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[100]  S. Davis,et al.  Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection. , 1994, Critical reviews in therapeutic drug carrier systems.

[101]  M. Schliwa,et al.  Powering membrane traffic in endocytosis and recycling , 2006, Nature Reviews Molecular Cell Biology.

[102]  M. Wientjes,et al.  Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule. , 2001, The Journal of pharmacology and experimental therapeutics.

[103]  A A Bogdanov,et al.  Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. , 1994, Biochimica et biophysica acta.

[104]  E. Giralt,et al.  Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape. , 2005, Biochemistry.

[105]  M. Hope,et al.  Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. , 2002, Biochimica et biophysica acta.

[106]  J. Au,et al.  Delivery of siRNA Therapeutics: Barriers and Carriers , 2010, The AAPS Journal.

[107]  H. McMahon,et al.  Mechanisms of endocytosis. , 2009, Annual review of biochemistry.

[108]  C. Davies,et al.  The impact of enzymatic degradation on the uptake of differently sized therapeutic molecules. , 2008, Anticancer research.

[109]  Yu Zhou,et al.  Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells. , 2007, Journal of molecular biology.

[110]  E. Vivés,et al.  TAT peptide internalization: seeking the mechanism of entry. , 2003, Current protein & peptide science.

[111]  Jessie L.-S. Au,et al.  Drug Delivery and Transport to Solid Tumors , 2003, Pharmaceutical Research.

[112]  R. Jain,et al.  Changes in tumour blood flow, oxygenation and interstitial fluid pressure induced by pentoxifylline. , 1994, British Journal of Cancer.

[113]  Wilson Mok,et al.  Multiscale measurements distinguish cellular and interstitial hindrances to diffusion in vivo. , 2009, Biophysical journal.

[114]  Vladimir P Torchilin,et al.  Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. , 2002, Cancer research.

[115]  M. Wientjes,et al.  Determinants of paclitaxel penetration and accumulation in human solid tumor. , 1999, The Journal of pharmacology and experimental therapeutics.

[116]  Ze Lu,et al.  Tumor-Penetrating Microparticles for Intraperitoneal Therapy of Ovarian Cancer , 2008, Journal of Pharmacology and Experimental Therapeutics.

[117]  R. Campbell,et al.  Development of 5-FU and Doxorubicin-Loaded Cationic Liposomes against Human Pancreatic Cancer: Implications for Tumor Vascular Targeting , 2006, Pharmaceutical Research.

[118]  S. Petrescu,et al.  Encapsulated cargo internalized by fusogenic liposomes partially overlaps the endoplasmic reticulum , 2009, Journal of cellular and molecular medicine.

[119]  Sung Wan Kim,et al.  Current status of polymeric gene delivery systems. , 2006, Advanced drug delivery reviews.

[120]  R K Jain,et al.  Solid stress facilitates spheroid formation: potential involvement of hyaluronan , 2002, British Journal of Cancer.

[121]  C. Miller,et al.  Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes. , 1998, Biochemistry.

[122]  Y. Kaneda,et al.  Virosomes: evolution of the liposome as a targeted drug delivery system. , 2000, Advanced drug delivery reviews.

[123]  R. Hynes.  A reevaluation of integrins as regulators of angiogenesis , 2002, Nature Medicine.

[124]  Bruce W. Erickson,et al.  Novel Long-circulating Liposomes Containing Peptide Library-lipid Conjugates: Synthesis and In Vivo Behavior , 2004, Journal of drug targeting.

[125]  Y. Tseng,et al.  Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study. , 2002, Molecular pharmacology.

[126]  Thomas J Hope,et al.  Role of the cytoskeleton in nuclear import. , 2003, Advanced drug delivery reviews.

[127]  F. Lejeune.  Clinical use of TNF revisited: improving penetration of anti-cancer agents by increasing vascular permeability. , 2002, The Journal of clinical investigation.

[128]  J. Gross,et al.  Microcirculatory studies in rat mammary carcinoma. I. Transparent chamber method, development of microvasculature, and pressures in tumor vessels. , 1980, Journal of the National Cancer Institute.

[129]  V. Torchilin.  Polymer-coated long-circulating microparticulate pharmaceuticals. , 1998, Journal of microencapsulation.

[130]  Dae-Duk Kim,et al.  Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[131]  Ű. Langel,et al.  CPP-protein constructs induce a population of non-acidic vesicles during trafficking through endo-lysosomal pathway. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[132]  J. Martinou,et al.  Cytochrome c release from mitochondria: all or nothing , 2000, Nature Cell Biology.

[133]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[134]  S. Moghimi,et al.  Serum factors that regulate phagocytosis of liposomes by Kupffer cells. , 1993, Biochemical Society transactions.

[135]  M. Giacca,et al.  Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. , 2004, The Journal of biological chemistry.

[136]  Yihui Deng,et al.  Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[137]  P. Alken,et al.  Paclitaxel encapsulated in cationic liposomes: a new option for neovascular targeting for the treatment of prostate cancer. , 2008, Oncology reports.

[138]  Shoji Tajima,et al.  Evaluation of pH-responsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[139]  A. Gabizon,et al.  Clinical pharmacology of liposomal anthracyclines: focus on pegylated liposomal Doxorubicin. , 2008, Clinical lymphoma & myeloma.

[140]  S. Futaki,et al.  Effect of polyethyleneglycol spacer on the binding properties of nuclear localization signal-modified liposomes to isolated nucleus. , 2009, Biological & pharmaceutical bulletin.

[141]  D. Tzemach,et al.  Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[142]  G. Palade,et al.  Neovasculature induced by vascular endothelial growth factor is fenestrated. , 1997, Cancer research.

[143]  F. Szoka,et al.  GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. , 2004, Advanced drug delivery reviews.

[144]  Vladimir P Torchilin,et al.  Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. , 2008, Advanced drug delivery reviews.

[145]  C. Cho,et al.  Efficient gene delivery using chitosan–polyethylenimine hybrid systems , 2008, Biomedical materials.

[146]  S. Futaki.  Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. , 2002, International journal of pharmaceutics.

[147]  S. Nir,et al.  Interactions of peptides with liposomes: pore formation and fusion. , 2000, Progress in lipid research.

[148]  Peter Gluchowski,et al.  F , 1934, The Herodotus Encyclopedia.

[149]  R. Jain,et al.  Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. , 1994, Cancer research.

[150]  A. Fader,et al.  Abraxane for the Treatment of Gynecologic Cancer Patients With Severe Hypersensitivity Reactions to Paclitaxel , 2009, International Journal of Gynecologic Cancer.

[151]  R K Jain,et al.  Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. , 1992, Cancer research.

[152]  You Han Bae,et al.  Recent progress in tumor pH targeting nanotechnology. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[153]  S. Wise.  Nanocarriers as an emerging platform for cancer therapy , 2007 .

[154]  D. Hirst,et al.  Nicotinamide reduces tumour interstitial fluid pressure in a dose- and time-dependent manner. , 1997, The British journal of radiology.

[155]  H. Lodish.  Molecular Cell Biology , 1986 .

[156]  D. Needham,et al.  Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol). , 1995, Biophysical journal.

[157]  H. Kessler,et al.  Ligands for mapping alphavbeta3-integrin expression in vivo. , 2009, Accounts of chemical research.

[158]  C. Benz,et al.  Future directions of liposome- and immunoliposome-based cancer therapeutics. , 2004, Seminars in oncology.

[159]  H Akita,et al.  Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid , 2007, Gene Therapy.

[160]  Vladimir P Torchilin,et al.  Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome–DNA complexes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[161]  Sérgio Simões,et al.  On the formulation of pH-sensitive liposomes with long circulation times. , 2004, Advanced drug delivery reviews.

[162]  Ű. Langel,et al.  Cell transduction pathways of transportans. , 2005, Bioconjugate chemistry.

[163]  D. Jans,et al.  Nuclear drug delivery to target tumour cells. , 2009, European journal of pharmacology.